Cytokinetics | CYTK - Current Liabilities

Stock Price
60.87
Daily Change
0.81 1.35%
Monthly
-8.63%
Yearly
35.54%
Q1 Forecast
58.25

Cytokinetics reported $202.45M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Acadia Pharmaceuticals USD 277.11M 79.47M Dec/2025
Amgen USD 25.49B 3.7B Dec/2025
Arca Biopharma USD 20.97M 8.86M Sep/2025
Bayer EUR 32.58B 3.63B Dec/2025
Biogen USD 3.35B 59.4M Dec/2025
Brainstorm Cell Therapeutics USD 9.02M 495K Sep/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Capricor Therapeutics USD 28.15M 249K Sep/2025
Cytokinetics USD 202.45M 60.31M Dec/2025
Eisai JPY 387.67B 9.42B Dec/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Exelixis USD 405.64M 31.86M Dec/2025
Geron USD 113.82M 26.11M Dec/2025
Halozyme Therapeutics USD 177.09M 660.14M Dec/2025
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
Ligand Pharmaceuticals USD 37.45M 6.91M Dec/2025
Merck USD 28.63B 2.59B Sep/2025
Novartis USD 32B 286M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Regeneron Pharmaceuticals USD 4.37B 56.7M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 28.35B 3.76B Dec/2025